Bridging the Gap Between Telehealth and Psychedelics Ketamine is the only FDA-approved psychedelic and has shown tons of promise in studies focused on treating depression, anxiety, and stress. With research being conducted on even more uses, such as to treat eating disorders, the ketamine sector is something to keep an eye on.
https://www.inverse.com/mind-body/ketamine-could-save-a-life/amp
$KETA.C is a company I've been watching for a while. They're combining 2 rapidly emerging sectors, ketamine and telehealth, to create a unique, safe, and effective psychedelic experience for their patients. The business operates on 3 main components.
- Consultation: Remotely meet with a licensed physician to create a customized treatment plan
- Fulfillment: Once approved, the oral ketamine prescription is delivered to your home
- Treatment: Schedule safe and secure treatment sessions with our Tripsitters. Tripsitters are people who are there to ensure that you have a positive experience and watch over you as you undergo the psychedelic treatment.
$KETA offers a one-of-a-kind experience from the comfort of your own home that helps both the physicians and patients save money. The stock has been hit hard since the IPO, but the long-term potential continues to look attractive. The downtrend is beginning to look like it's losing some momentum, and we could see the bottom very soon as support levels begin to strengthen. It's currently breaking out 27% today with a market cap of only $9M.